Vivotif: payments to doctors
Payments that named Vivotif as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $93K
- Providers
- 271
- Transactions
- 346
- Average per transaction
- $268
The per-transaction average — $268 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 271 providers the average total is $342, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Emergent Biosolutions Inc. | $86,485 | 93.3% |
| Bavarian Nordic A/s | $6,198 | 6.7% |